menu search

Structure therapeutics: developing innovative treatments for metabolic and fibrotic diseases

Structure Therapeutics has a promising pipeline of product candidates, including GSBR-1290, a GLP-1R agonist for diabetes and obesity, and APJR and LP...

April 12, 2023, 4:31 pm

Viking (vktx) announces clinical data for metabolic disorders

Viking (VKTX) announces positive clinical data, evaluating VK2735 to treat metabolic disorders. It is a...

March 29, 2023, 12:14 pm

Reshape lifesciences® to delay year ended december 31, 2022 earnings release and conference call

SAN CLEMENTE, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and ...

March 28, 2023, 9:50 pm

Here's why viking therapeutics rose over 50% on obesity drug data

Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GL...

March 28, 2023, 1:01 pm

Relief therapeutics to present pre-clinical evidence for improved amino acid utilization with pku golike at the society for inherited metabolic disorders 44th annual meeting

The results of the preclinical study demonstrate improved muscle anabolism and function with a prolonged-release amino acid supplement using Physiomim...

March 17, 2023, 6:25 pm

Reviva pharmaceuticals to present at the 35th annual roth conference

CUPERTINO, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...

March 7, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c

SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

February 21, 2023, 8:00 am

Structure therapeutics announces pricing of upsized initial public offering

SAN FRANCISCO and SHANGHAI, China, Feb. 02, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceu...

February 3, 2023, 12:41 am

Reviva pharmaceuticals announces letter to shareholders

CUPERTINO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...

January 4, 2023, 11:00 am

Lilly, sosei to develop new treatments for diabetes and metabolic diseases

Eli Lilly & Co. Inc. and Sosei Group Corp. said Friday they plan to develop and commercialize therapies for diabetes and ...

December 16, 2022, 7:50 am

Corcept therapeutics settles patent litigation with hikma pharmaceuticals

MENLO PARK, Calif., Dec. 08, 2022 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the dis...

December 8, 2022, 1:00 pm

Amgen, inc. (amgn) american heart association (aha) scientific sessions 2022 transcript

Amgen, Inc. (NASDAQ:AMGN ) American Heart Association (AHA) Scientific Sessions 2022 November 8, 2022 4:30 AM ET Company Participants David Reese - EV...

November 12, 2022, 8:52 pm

Eiger biopharmaceuticals, inc. (eigr) q3 2022 earnings call transcript

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR ) Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Sarah Mathieson - Senio...

November 3, 2022, 9:25 pm

Reviva pharmaceuticals to present at the h.c. wainwright 24th annual global investment conference

CUPERTINO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...

September 7, 2022, 8:02 am

Eiger biopharmaceuticals, inc. (eigr) ceo david cory on q2 2022 results - earnings call transcript

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, C...

August 6, 2022, 8:23 pm

Viking therapeutics to report financial results for second quarter 2022 on july 27, 2022

Conference Call Scheduled for Wednesday, July 27 at 4:30 p.m. Eastern Time SAN DIEGO , July 20, 2022 /PRNewswire/ -- Viking Therapeutics, Inc. ("Vikin...

July 20, 2022, 4:02 pm

Synlogic to present at the 2022 national pku alliance (npkua) conference

VANCOUVER, Wash., June 28, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for ...

June 28, 2022, 7:00 am

Biomea fusion to present new preclinical data showing bmf-219's strong activity in relapsed/refractory chronic lymphocytic leukemia (cll) tumor models at asco 2022

REDWOOD CITY, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to dis...

May 26, 2022, 6:30 pm


Search within

Pages Search Results: